Tenet Healthcare Corporation (THC)
What Makes Tenet Healthcare (THC) a Strong Momentum Stock: Buy Now?
Does Tenet Healthcare (THC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Tenet Healthcare (THC) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tenet Healthcare Corporation (THC) Hit a 52 Week High, Can the Run Continue?
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Despite Fast-paced Momentum, Tenet (THC) Is Still a Bargain Stock
Tenet (THC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Tenet Healthcare Stock Climbed to a 22-Year High Today. Here's Why
Tenet Healthcare (THC) shares soared to a more than two-decade high after the hospital and surgical center chain posted stronger-than-expected results and boosted its outlook as it brought in more patients who paid more for services.
Tenet (THC) Q2 Earnings Beat on Patient Volumes, '24 EPS View Up
Tenet Healthcare's (THC) Q2 results reflect net revenue per case growth, higher pricing yield and a decline in overall expenses. It expects 2024 adjusted EPS within $10.41-$11.12, up from the previous guidance of $8.37-$9.41.
Tenet (THC) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Tenet (THC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Hospital Operator Tenet Healthcare Exceeds Earnings Expectations, Announces Share Buyback Of $1.5B
On Wednesday, Tenet Healthcare Corporation THC reported first-quarter sales of $5.37 billion, up around 7% year over year, beating the consensus of $5.15 billion.
Tenet Healthcare (THC) Q2 Earnings and Revenues Beat Estimates
Tenet Healthcare (THC) came out with quarterly earnings of $2.31 per share, beating the Zacks Consensus Estimate of $1.89 per share. This compares to earnings of $1.44 per share a year ago.
Tenet (THC) Upgraded to Strong Buy: Here's What You Should Know
Tenet (THC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
